BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Canale V, Partyka A, Kurczab R, Krawczyk M, Kos T, Satała G, Kubica B, Jastrzębska-Więsek M, Wesołowska A, Bojarski AJ, Popik P, Zajdel P. Novel 5-HT7R antagonists, arylsulfonamide derivatives of (aryloxy)propyl piperidines: Add-on effect to the antidepressant activity of SSRI and DRI, and pro-cognitive profile. Bioorg Med Chem 2017;25:2789-99. [PMID: 28391970 DOI: 10.1016/j.bmc.2017.03.057] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 García-Durán L, Flores-Burgess A, Cantero-García N, Puigcerver A, Narváez JÁ, Fuxe K, Santín L, Millón C, Díaz-Cabiale Z. Galanin(1-15) Potentiates the Antidepressant-like Effects Induced by Escitalopram in a Rat Model of Depression. Int J Mol Sci 2021;22:10848. [PMID: 34639188 DOI: 10.3390/ijms221910848] [Reference Citation Analysis]
2 Ali Z, Tegin C, El-mallakh RS. Evaluating lurasidone as a treatment option for bipolar disorder. Expert Opinion on Pharmacotherapy 2020;21:253-60. [DOI: 10.1080/14656566.2019.1695777] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Thirumaran S, Lepailleur A, Rochais C. Structure-activity relationships of serotonin 5-HT7 receptors ligands: A review. European Journal of Medicinal Chemistry 2019;183:111705. [DOI: 10.1016/j.ejmech.2019.111705] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wyszogrodzka E, Dyr W, Siwińska-Ziółkowska A, Mierzejewski P. Higher sensitivity to ethanol's aversive properties in WLP (Warsaw Low Preferring) vs. WHP (Warsaw High Preferring) rats. Alcohol 2021;90:67-73. [PMID: 33352200 DOI: 10.1016/j.alcohol.2020.12.002] [Reference Citation Analysis]
5 Wang L, Zhang Y, Du X, Ding T, Gong W, Liu F. Review of antidepressants in clinic and active ingredients of traditional Chinese medicine targeting 5-HT1A receptors. Biomedicine & Pharmacotherapy 2019;120:109408. [DOI: 10.1016/j.biopha.2019.109408] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
6 Canale V, Frisi V, Bantreil X, Lamaty F, Zajdel P. Sustainable Synthesis of a Potent and Selective 5-HT7 Receptor Antagonist Using a Mechanochemical Approach. J Org Chem 2020;85:10958-65. [PMID: 32706254 DOI: 10.1021/acs.joc.0c01044] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
7 Marciniec K, Kurczab R, Książek M, Bębenek E, Chrobak E, Satała G, Bojarski AJ, Kusz J, Zajdel P. Structural determinants influencing halogen bonding: a case study on azinesulfonamide analogs of aripiprazole as 5-HT1A, 5-HT7, and D2 receptor ligands. Chem Cent J 2018;12:55. [PMID: 29748774 DOI: 10.1186/s13065-018-0422-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
8 Modica MN, Lacivita E, Intagliata S, Salerno L, Romeo G, Pittalà V, Leopoldo M. Structure-Activity Relationships and Therapeutic Potentials of 5-HT7 Receptor Ligands: An Update. J Med Chem 2018;61:8475-503. [PMID: 29767995 DOI: 10.1021/acs.jmedchem.7b01898] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
9 Partyka A, Jastrzębska-więsek M, Antkiewicz-michaluk L, Michaluk J, Wąsik A, Canale V, Zajdel P, Kołaczkowski M, Wesołowska A. Novel antagonists of 5-HT6 and/or 5-HT7 receptors affect the brain monoamines metabolism and enhance the anti-immobility activity of different antidepressants in rats. Behavioural Brain Research 2019;359:9-16. [DOI: 10.1016/j.bbr.2018.10.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Kucwaj-brysz K, Kurczab R, Jastrzębska-więsek M, Żesławska E, Satała G, Nitek W, Partyka A, Siwek A, Jankowska A, Wesołowska A, Kieć-kononowicz K, Handzlik J. Computer-aided insights into receptor-ligand interaction for novel 5-arylhydantoin derivatives as serotonin 5-HT 7 receptor agents with antidepressant activity. European Journal of Medicinal Chemistry 2018;147:102-14. [DOI: 10.1016/j.ejmech.2018.01.093] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
11 Canale V, Kotańska M, Dziubina A, Stefaniak M, Siwek A, Starowicz G, Marciniec K, Kasza P, Satała G, Duszyńska B, Bantreil X, Lamaty F, Bednarski M, Sapa J, Zajdel P. Design, Sustainable Synthesis and Biological Evaluation of a Novel Dual α2A/5-HT7 Receptor Antagonist with Antidepressant-Like Properties. Molecules 2021;26:3828. [PMID: 34201675 DOI: 10.3390/molecules26133828] [Reference Citation Analysis]